Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong

BACKGROUND: Cost and quality-adjusted life-years (QALYs) gained by quadrivalent influenza vaccine (QIV) versus trivalent influenza vaccine (TIV) in Hong Kong elderly were estimated over 9 seasons. METHODS: TIV-unmatched influenza B infection rates with QIV versus TIV were estimated by an epidemiolog...

Descripción completa

Detalles Bibliográficos
Autores principales: You, Joyce HS, Ming, Wai-kit, Chan, Paul KS
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246550/
https://www.ncbi.nlm.nih.gov/pubmed/25420713
http://dx.doi.org/10.1186/s12879-014-0618-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4246550/
https://www.ncbi.nlm.nih.gov/pubmed/25420713
http://dx.doi.org/10.1186/s12879-014-0618-9

Ejemplares similares